Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic abe...
Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
To understand functional consequences of genetic and transcriptional aberrations in prostate cancer, the proteomic changes during disease formation and progression need to be revealed. Here we report high-throughput mass spectrometry on clinical tissue samples of benign prostatic hyperplasia (BPH), untreated primary prostate cancer (PC) and castrat...
Alternative Titles
Full title
Integrative proteomics in prostate cancer uncovers robustness against genomic and transcriptomic aberrations during disease progression
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_61f749925834414ebb92c52acbc5d9a6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_61f749925834414ebb92c52acbc5d9a6
Other Identifiers
ISSN
2041-1723
E-ISSN
2041-1723
DOI
10.1038/s41467-018-03573-6
